GH Research (GHRS) Non Operating Income (2022 - 2024)
GH Research (GHRS) recorded quarterly Non Operating Income of $3.9 million in Q1 2024, up 845.56% quarter-over-quarter from -$518000.0 in Q1 2023, and up 845.56% on a YoY basis from $408435.3 in Q2 2023.
GH Research (GHRS) Non Operating Income (2022 - 2024) Analysis & Trends
GH Research's Non Operating Income history runs 3 years deep, the most recent figure standing at $3.9 million for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 9.35 Mn |
| 10 | GH Research | 9.73 Bn | 9.63 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 3.86 Mn |
| Mar 31, 2023 | -518,000.00 |
| Mar 31, 2022 | 2.24 Mn |